Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.

Koeberl, Dwight D

Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. [electronic resource] - FASEB journal : official publication of the Federation of American Societies for Experimental Biology May 2014 - 2171-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1530-6860

10.1096/fj.13-241893 doi


Adrenergic beta-2 Receptor Agonists--therapeutic use
Albuterol--therapeutic use
Biopsy
Electrocardiography
Enzyme Replacement Therapy--methods
Female
Glycogen Storage Disease Type II--drug therapy
Hand Strength
Humans
Male
Muscle, Skeletal--metabolism
Pilot Projects
Quadriceps Muscle--metabolism
Receptor, IGF Type 2--metabolism
Time Factors
Treatment Outcome
Walking